41-oxo-45-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontanoic acid
- Catalog No. :
- ACBDGC849
- CAS No. :
- 1621423-14-0
- Molecular Formula :
- C37H69N3O16S
- Molecular Weight :
- 843.44
IUPAC Name:41-oxo-45-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontanoic acid
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$211.00Login to see priceIn stockInquiry
100mg98%$356.00Login to see priceIn stockIn stock
250mg98%$710.00Login to see priceIn stockIn stock
1g98%$2272.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | 41-oxo-45-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontanoic acid |
|---|---|
| IUPAC Name | 41-oxo-45-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontanoic acid |
| MDL No. | MFCD08274601 |
| Molecular Formula | C37H69N3O16S |
| Molecular Weight | 843.44 |
| SMILES | OC(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCCC[C@H]1[C@]2([H])[C@](NC(N2)=O)([H])CS1)=O)=O |
| InChI Key | AEMUKWXFLKZKMD-UEMWQVMZSA-N |
| Synonym | Biotin-PEG12-Acid;(+)-Biotin-PEG12-CH2CH2COOH;4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxa-40-azapentatetracontanoic acid, 45-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-41-oxo-;(+)-Biotin-PEG12-acid;Biotin-PEG12-CH2CH2COOH/4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxa-40-azapentatetracontanoic acid, 45-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-41-oxo-;ALPHA-BIOTIN-OMEGA-(PROPIONIC ACID)-DODECAE(ETHYLENE GLYCOL) |
| CAS No. | 1621423-14-0 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338
